DOCSLIB.ORG

Current Barriers to Patient Access to Medicinal Cannabis in Australia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Current Barriers to Patient Access to Medicinal Cannabis in Australia The Senate Community Affairs References Committee Current barriers to patient access to medicinal cannabis in Australia March 2020 © Commonwealth of Australia 2020 ISBN 978-1-76093-059-2 (Printed Version) ISBN 978-1-76093-059-2 (HTML Version) This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Australia License. The details of this licence are available on the Creative Commons website: http://creativecommons.org/licenses/by-nc-nd/3.0/au/. Printed by the Senate Printing Unit, Parliament House, Canberra Committee Members Chair Senator Rachel Siewert AG, WA Deputy Chair Senator Wendy Askew LP, TAS Members Senator Catryna Bilyk ALP, TAS (from 5 February 2020) Senator Raff Ciccone ALP, VIC (from 5 December 2019 to 5 February 2020) Senator Hollie Hughes LP, NSW Senator Malarndirri McCarthy ALP, NT Senator Anne Urquhart ALP, TAS Participating Members Senator Catryna Bilyk ALP, TAS (until 5 February 2020) Senator Richard Di Natale AG, VIC Former Members Senator Deborah O'Neill ALP, NSW (until 5 December 2019) Secretariat Jeanette Radcliffe, Committee Secretary Apolline Kohen, Principal Research Officer Kathleen McGarry, Acting Senior Research Officer Carol Stewart, Administrative Officer PO Box 6100 Parliament House Canberra ACT 2600 Phone: 02 6277 3515 Fax: 02 6277 5829 E-mail: [email protected] Internet: www.aph.gov.au/senate_ca iii Table of Contents Committee Members ........................................................................................................................ iii Terms of Reference ............................................................................................................................ ix Abbreviations ..................................................................................................................................... xi List of Recommendations .............................................................................................................. xiii Chapter 1—Introduction .................................................................................................................... 1 Purpose of the inquiry ......................................................................................................................... 1 Report structure ................................................................................................................................... 1 Conduct of the inquiry ........................................................................................................................ 2 Acknowledgements .................................................................................................................. 2 Note on terminology and references ...................................................................................... 2 Medicinal cannabis .............................................................................................................................. 2 Medicinal uses ........................................................................................................................... 3 The role of the Therapeutic Goods Administration (TGA) ............................................................ 3 Scheduling of medicines .......................................................................................................... 3 Registration of medicines ........................................................................................................ 4 Access pathways for medicinal cannabis .............................................................................. 5 The role of the Office of Drug Control (ODC) ................................................................................. 7 The role of state and territory governments ..................................................................................... 7 SAS online system ..................................................................................................................... 9 Chapter 2—Education and information ........................................................................................ 11 Education about medicinal cannabis .............................................................................................. 12 Medical cannabis efficacy ...................................................................................................... 12 Treatment of last resort .......................................................................................................... 13 Stigma ....................................................................................................................................... 14 Training ............................................................................................................................................... 15 Training available ................................................................................................................... 16 Training needs ......................................................................................................................... 16 Information about accessing medicinal cannabis .......................................................................... 17 Patients' perspectives ............................................................................................................. 17 Health practitioners' perspectives ........................................................................................ 18 v Medicinal cannabis products ................................................................................................ 19 Committee view ................................................................................................................................. 19 Chapter 3—Access pathways and regulatory hurdles ................................................................ 23 Introduction ........................................................................................................................................ 23 Special Access Scheme....................................................................................................................... 23 Use of SAS-A ........................................................................................................................... 24 Recent increase in SAS-B applications ................................................................................. 24 Concerns about using the SAS-B pathway .......................................................................... 26 Authorised Prescriber scheme ......................................................................................................... 31 Clinical trials ....................................................................................................................................... 35 Alternatives proposed to the current TGA pathways .................................................................. 36 Proposal for an independent regulatory framework ......................................................... 37 Committee view ................................................................................................................................. 39 Notification pathways ............................................................................................................ 39 Approval pathways ................................................................................................................ 40 Committee view ................................................................................................................................. 41 Jurisdiction-specific regulatory requirements ............................................................................... 43 The 'postcode lottery' ............................................................................................................. 44 Tasmania – the odd state out ................................................................................................ 46 Need for harmonisation ......................................................................................................... 47 International jurisdictions and their access models ...................................................................... 48 The Canadian model .............................................................................................................. 49 Committee view ................................................................................................................................. 50 Chapter 4—Products and supply ................................................................................................... 53 Regulating medicinal cannabis products ....................................................................................... 53 Scheduling in the Poisons Standard ..................................................................................... 54 Registration of medicinal cannabis products in the ARTG .............................................. 57 Regulating cannabinoids as complementary medicines ................................................... 62 Committee view ................................................................................................................................. 63 Medicinal cannabis supply in Australia ......................................................................................... 64 Locally-manufactured medicinal cannabis products .......................................................
Load more

Recommended publications
  • The Tocsin | Issue 12, 2021
    Contents The Tocsin | Issue 12, 2021 Editorial – Shireen Morris and Nick Dyrenfurth | 3 Deborah O’Neill – The American Warning | 4 Kimberley Kitching – Super Challenges | 7 Kristina Keneally – Words left unspoken | 10 Julia Fox – ‘Gender equality is important but …’ | 12 In case you missed it ... | 14 Clare O’Neil – Digital Dystopia? | 16 Amanda Rishworth – Childcare is the mother and father of future productivity gains | 18 Shireen Morris – Technology, Inequality and Democratic Decline | 20 Robynne Murphy – How women took on a giant and won | 24 Shannon Threlfall-Clarke – Front of mind | 26 The Tocsin, Flagship Publication of the John Curtin Research Centre. Issue 12, 2021. Copyright © 2021 All rights reserved. Editor: Nick Dyrenfurth | [email protected] www.curtinrc.org www.facebook.com/curtinrc/ twitter.com/curtin_rc Editorial Executive Director, Dr Nick Dyrenfurth Committee of Management member, Dr Shireen Morris It was the late, trailblazing former Labor MP and Cabinet Minister, Susan Ryan, who coined the memorable slogan ‘A must be identified and addressed proactively. We need more Woman’s Place is in the Senate’. In 1983, Ryan along with talented female candidates being preselected in winnable seats. Ros Kelly were among just four Labor women in the House of We need more female brains leading in policy development Representatives, together with Joan Child and Elaine Darling. and party reform, beyond the prominent voices on the front As the ABC notes, federal Labor boasts more than double the bench. We need to nurture new female talent, particularly number of women in Parliament and about twice the number women from working-class and migrants backgrounds.
    [Show full text]
  • Let Her Finish: Gender, Sexism, and Deliberative Participation in Australian Senate Estimates Hearings (2006-2015)
    Let Her Finish: Gender, Sexism, and Deliberative Participation In Australian Senate Estimates Hearings (2006-2015) Joanna Richards School of Government and Policy Faculty of Business, Government and Law University of Canberra ABSTRACT In 2016, Australia ranks 54th in the world for representation of women in Parliament, with women ​ accounting for only 29% of the House of Representatives, and 39% of the Senate. This inevitably ​ inspires discussion about women in parliament, quotas, and leadership styles. Given the wealth of research which suggests that equal representation does not necessarily guarantee equal treatment, this study focuses on Authoritative representation. That is, the space in between winning a seat and making a difference where components of communication and interaction affect the authority of a speaker.This study combines a Discourse Analysis of the official Hansard transcripts from the Senate Estimates Committee hearings, selected over a 10 year period between 2006 and 2015, with a linguistic ethnography of the Australian Senate to complement results with context. Results show that although female senators and witnesses are certainly in the room, they do not have the same capacity as their male counterparts. Both the access and effectiveness of women in the Senate is limited; not only are they given proportionally less time to speak, but interruption, gate keeping tactics, and the designation of questions significantly different in nature to those directed at men all work to limit female participation in the political domain. As witnesses, empirical measures showed that female testimony was often undermined by senators. Results also showed that female senators and witnesses occasionally adopted masculine styles of communication in an attempt to increase effectiveness in the Senate.
    [Show full text]
  • Cannabis & Hemp Guide
    ® MEDICINAL CANNABIS & HEMP GUIDE © AN INFORMATIVE AND EDUCATIONAL NEWSLETTER TO HELP PEOPLE UNDERSTAND THE BENEFITS OF MEDICINAL CANNABIS AND HEMP. A LIFE SAVING, NATURAL GROWING HERB. TO HELP REMOVE THE "UNWARRANTED'' STIGMA THAT HAS BEEN ATTACHED TO IT AND TO DISPEL THE MYTHS SURROUNDING ITS USE Compiled by Andrew Irving - Medicinal Cannabis & Hemp Tasmania® Passionate Advocate for the Legalisation of Medicinal Cannabis September / October 2018 - Issue 18 ISSN 2206-2807 Hello everyone Sadly we lose another canna warrior “Richelle Lincoln” R.I P. Read about her in this issue, as we send our heart felt condolences to family and friends. So Canada leaps ahead and legalises Cannabis, and where do we find ourselves in this backward nation of Australia??? Yes, you guessed it, absolutely nowhere, dare I say baby steps?? And if that’s the case it’s a very small baby with short legs…. If that isn’t bad enough, we now hear South Australia is going in the opposite direction, back to the dark ages, and wanting to quadruple cannabis pocession fines, with long jail sentences. For a “herb” ????? If it wasn’t so seriously ridiculous it would indeed be laughable. Little Green Trailer Tasmania is moving along in leaps and bounds, having been invited to various events. Read about it, and how you can assist in this issue also. The thirst for MC education is phenomenal, and growing, which is keeping us very busy. I have zero interest in politics, however, here in Tasmania the opposition Labor party have shown massive interest in this cause for legalisation.
    [Show full text]
  • HON. GIZ WATSON B. 1957
    PARLIAMENTARY HISTORY ADVISORY COMMITTEE AND STATE LIBRARY OF WESTERN AUSTRALIA TRANSCRIPT OF AN INTERVIEW WITH HON. GIZ WATSON b. 1957 - STATE LIBRARY OF WESTERN AUSTRALIA - ORAL HISTORY COLLECTION DATE OF INTERVIEW: 2015-2016 INTERVIEWER: ANNE YARDLEY TRANSCRIBER: ANNE YARDLEY DURATION: 19 HOURS REFERENCE NUMBER: OH4275 COPYRIGHT: PARLIAMENT OF WESTERN AUSTRALIA & STATE LIBRARY OF WESTERN AUSTRALIA. GIZ WATSON INTERVIEW TRANSCRIPTS NOTE TO READER Readers of this oral history memoir should bear in mind that it is a verbatim transcript of the spoken word and reflects the informal, conversational style that is inherent in such historical sources. The Parliament and the State Library are not responsible for the factual accuracy of the memoir, nor for the views expressed therein; these are for the reader to judge. Bold type face indicates a difference between transcript and recording, as a result of corrections made to the transcript only, usually at the request of the person interviewed. FULL CAPITALS in the text indicate a word or words emphasised by the person interviewed. Square brackets [ ] are used for insertions not in the original tape. ii GIZ WATSON INTERVIEW TRANSCRIPTS CONTENTS Contents Pages Introduction 1 Interview - 1 4 - 22 Parents, family life and childhood; migrating from England; school and university studies – Penrhos/ Murdoch University; religion – Quakerism, Buddhism; countryside holidays and early appreciation of Australian environment; Anti-Vietnam marches; civil-rights movements; Activism; civil disobedience; sport; studying environmental science; Albany; studying for a trade. Interview - 2 23 - 38 Environmental issues; Campaign to Save Native Forests; non-violent Direct Action; Quakerism; Alcoa; community support and debate; Cockburn Cement; State Agreement Acts; campaign results; legitimacy of activism; “eco- warriors”; Inaugural speech .
    [Show full text]
  • Time for Submissions to Inquiry Into Building Inclusive and Accessible Communities
    Senate Community Affairs References Committee More time for submissions to inquiry into building inclusive and accessible communities The Senate Community Affairs References Committee is inquiring into the delivery of outcomes under the National DATE REFERRED Disability Strategy 2010-2020 to build inclusive and 29 December 2016 accessible communities. SUBMISSIONS CLOSE The inquiry will examine the planning, design, management 28 April 2017 and regulation of the built and natural environment, transport services and infrastructure, and communication and NEXT HEARING information systems, including barriers to progress or To be advised innovation in these areas. It will also look at the impact of restricted access for people with disability on inclusion and REPORTING DATE participation in all aspects of life. 13 September 2017 The date for submissions to the inquiry has been extended to COMMITTEE MEMBERSHIP Friday 28 April 2017. Senator Rachel Siewert (Chair) "The additional time will ensure that groups and individuals Senator Jonathon Duniam can make a contribution to the inquiry" said committee chair, (Deputy Chair) Senator Sam Dastyari Senator Rachel Siewert. "The committee is very keen to hear Senator Louise Pratt directly from people with disability and their families and Senator Linda Reynolds carers, as well as representative organisations. We would also Senator Murray Watt welcome submissions from service providers and innovators Senator Carol Brown who have improved accessibility in their communities or online." CONTACT THE COMMITTEE Senate Standing Committees "The committee encourages people to visit the committee's on Community Affairs website to get some more information about the inquiry and PO Box 6100 how to make a submission.
    [Show full text]
  • Australia's Faunal Extinction Crisis
    The Senate Environment and Communications References Committee Australia’s faunal extinction crisis Interim report April 2019 © Commonwealth of Australia 2019 ISBN 978-1-76010-967-7 Committee contact details PO Box 6100 Parliament House Canberra ACT 2600 Tel: 02 6277 3526 Fax: 02 6277 5818 Email: [email protected] Internet: www.aph.gov.au/senate_ec This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Australia License. The details of this licence are available on the Creative Commons website: http://creativecommons.org/licenses/by-nc-nd/3.0/au/. This document was printed by the Senate Printing Unit, Parliament House, Canberra Committee membership Committee members Senator Janet Rice, Chair AG, Tasmania Senator Jonathan Duniam, Deputy Chair LP, Tasmania Senator Anthony Chisholm ALP, Queensland Senator the Hon Kristina Keneally ALP, New South Wales Senator Steve Martin NATS, Tasmania Senator Anne Urquhart ALP, Tasmania Substitute member for this inquiry Senator Carol Brown (ALP, TAS) for Senator Anne Urquhart on 4 February 2019 Senator Murray Watt (ALP, QLD) for Senator Anthony Chisholm on 31 January 2019 and 1 February 2019 Participating members for this inquiry Senator Larissa Waters AG, Queensland Senator Peter Whish-Wilson AG, Tasmania Committee secretariat Ms Christine McDonald, Committee Secretary Mr Nicholas Craft, Principal Research Officer Ms Nicola Knackstredt, Acting Principal Research Officer Mr Michael Perks, Research Officer Ms Georgia Fletcher, Administrative Officer iii iv Table of contents
    [Show full text]
  • Better Access Australia
    BETTER ACCESS AUSTRALIA CALLS FOR SENATE INTERVENTION ON OPIATE DEPENDENCE TREATMENT PROGRAM Better Access Australia has written to the Senate Standing Committee for the Scrutiny of Delegated Legislation seeking their urgent intervention to end the financial discrimination for patients accessing opiate dependence medicines on the Pharmaceutical Benefits Scheme. “After weeks of inaction on this issue by the Minister of Health the Hon Greg Hunt MP, Better Access Australia is calling on the Parliament to urgently review the legal basis for this continuing discrimination and end the gap in access for some of the most vulnerable in our community. “Why are these the only medicines on the PBS where a patient can be denied their co- payment and safety net protections and be charged unlimited out of pocket expenses on a daily basis at the recommendation of the government? And on what basis is this program denying these patients their legal protections under the National Health Act 1953? “The Government and its advisory committees acknowledge that over 75% of patients accessing these medicines are facing these out-of-pocket costs, and further acknowledge those costs are a barrier to people accessing treatment for their chronic disease. “The time has come to end the arguments about cost-shifting with the states and territories and put the patient at the centre of the system. “The time has also come for the Government and the Parliament to stop and consider whether what they are doing is legal under the National Health Act, legal under the Legislation Act 2003 and legal under the Antidiscrimination Act.
    [Show full text]
  • Senate Chamber Seating Plan AS at 15 June 2020 Advisers President Advisers
    Senate Chamber Seating Plan AS AT 15 June 2020 Advisers President Advisers RYAN VIC/LP CLERK CHAIR DEPUTY Government Whips OF COMMITTEES CLERK Opposition Whips BLACK D. SMITH RUSTON K. GALLAGHER URQUHART LINES ROD WA/LP SA/LP ACT/ALP TAS/ALP WA/ALP McGRATH CASH KENEALLY CICCONE McCARTHY QLD/LP WA/LP NSW/ALP VIC/ALP NT/ALP BROCKMAN ABETZ PAYNE Ministers FARRELL KITCHING O'NEILL WA/LP TAS/LP NSW/LP BIRMINGHAM WONG SA/ALP VIC/ALP NSW/ALP SA/LP SA/ALP CHANDLER FIERRAVANTI-WELLS REYNOLDS Leader Leader WATT AYRES WALSH TAS/LP NSW/LP WA/LP QLD/ALP NSW/ALP VIC/ALP of the of the Government Opposition Shadow Ministers ANTIC FAWCETT COLBECK McALLISTER POLLEY CHISHOLM SA/LP SA/LP TAS/LP NSW/ALP TAS/ALP QLD/ALP HENDERSON PATERSON SESELJA BROWN GREEN CARR VIC/LP VIC/LP ACT/LP TAS/ALP QLD/ALP VIC/ALP RENNICK MOLAN HUME DODSON BILYK QLD/LP NSW/LP VIC/LP WA/ALP TAS/ALP VAN ASKEW DUNIAM STERLE SHELDON VIC/LP TAS/LP TAS/LP Hansard WA/ALP NSW/ALP Reporters McLACHLAN SCARR STOKER PRATT A. GALLACHER SA/LP QLD/LP QLD/LP WA/ALP SA/ALP SMALL HUGHES M. SMITH WA/LP NSW/LP SA/ALP BRAGG PATRICK NSW/LP LAMBIE TAS/JLN SA/IND O'SULLIVAN WA/LP GRIFF McKENZIE SIEWERT SA/CA VIC/NAT WA/AG DAVEY RICE NSW/NAT HANSON WATERS VIC/AG QLD/PHON CANAVAN QLD/AG McDONALD QLD/NAT WHISH-WILSON QLD/NAT TAS/AG HANSON-YOUNG ROBERTS McKIM SA/AG QLD/PHON McMAHON TAS/AG THORPE NT/CLP VIC/AG FARUQI STEELE-JOHN NSW/AG WA/AG Advisers Advisers Senate Office Holders & Ministerial Representation in the Senate 46th Parliament • 3 August 2021 • The Parliament of the Commonwealth of Australia Senate Office Holders Senate Party Leaders President: Senator the Hon.
    [Show full text]
  • Community Affairs Legislation Committee
    The Senate Community Affairs Legislation Committee Additional estimates 2019–20 March 2020 Commonwealth of Australia 2020 978-1-76093-063-9 Secretariat Ms Jeanette Radcliffe (Committee Secretary) Ms Sarah Batts (Research Officer) PO Box 6100 Parliament House Canberra ACT 2600 Phone: 02 6277 3515 Fax: 02 6277 5829 E-mail: [email protected] Internet: www.aph.gov.au/senate_ca This document was produced by the Senate Community Affairs Committee Secretariat and printed by the Senate Printing Unit, Parliament House, Canberra. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Australia License. The details of this licence are available on the Creative Commons website: http://creativecommons.org/licenses/by-nc-nd/3.0/au/ ii MEMBERSHIP OF THE COMMITTEE 46th Parliament Members Senator Wendy Askew, Chair Tasmania, LP Senator Rachel Siewert, Deputy Chair Western Australia, AG Senator Malarndirri McCarthy Northern Territory, ALP Senator Andrew McLachlan South Australia, LP Senator Helen Polley Tasmania, ALP Senator Dean Smith Western Australia, LP Senators in attendance Senators Bilyk, Chandler, Di Natale, Dodson, Farrell, Gallagher, Griff, Hughes, Keneally, Kitching, Lines, O'Neill, O'Sullivan, Patrick, Rice, Roberts, Sheldon, Marielle Smith, Steele-John, Urquhart, Waters, Watt. iv TABLE OF CONTENTS Membership of the Committee ........................................................................ iii Abbreviations ....................................................................................................vii
    [Show full text]
  • Baas Letter to the Senate Standing Committee
    8 March 2021 Senator the Hon Concetta Fierravanti-Wells Senator the Hon Kim Carr Senator Raff Ciccone Senator Perin Davey Senator Nita Green Senator Paul Scarr The Senate Standing Committee for the Scrutiny of Delegated Legislation Australian Parliament House Dear Senators Request for Committee Intervention on Unlawful Exercise of Delegated Powers Better Access Australia was established in September 2020 to advance improvements in health, disability, and social services to achieve better access and continuity of care for all Australians by 2030. We are writing to you in your role as members of the Senate Standing Committee for the Scrutiny of Delegated Legislation to bring to your attention, and seek your action upon, what we believe to be an unlawful exercise of power under the National Health Act 1953 using delegated powers. We also consider that in exercising this delegation the Department of Health has breached anti- discrimination laws in its administration of the Pharmaceutical Benefits Scheme (PBS). Had the exercise of these delegated powers been subject to the scrutiny of Parliament, which in our opinion is legally required, then this discrimination could have been prevented. We seek your urgent attention to address this matter which is impacting on some of the most vulnerable in the community. Why we believe the current exercise of power is unlawful Subsection 100(1) of the National Health Act 1953 enables the Minister or their delegate to “make special arrangements for, or in relation to, providing that an adequate supply of pharmaceutical benefits will be available to persons.” These arrangements can be made through delegated instruments.
    [Show full text]
  • Impact of the 2014 and 2015 Commonwealth Budget Decisions on the Arts
    The Senate Legal and Constitutional Affairs References Committee Impact of the 2014 and 2015 Commonwealth Budget decisions on the Arts December 2015 Commonwealth of Australia 2015 ISBN 978-1-76010-335-4 This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Australia License. The details of this licence are available on the Creative Commons website: http://creativecommons.org/licenses/by-nc-nd/3.0/au/. This document was produced by the Senate Legal and Constitutional Affairs Committee secretariat and printed by the Senate Printing Unit, Department of the Senate, Parliament House, Canberra. ii Members of the committee Members Senator Penny Wright (AG, SA) (Chair) until 24.6.2015 Senator Glenn Lazarus (IND, QLD) (Chair) from 25.6.2015 Senator the Hon Ian Macdonald (LP, QLD) (Deputy Chair) Senator Catryna Bilyk (ALP, TAS) Senator Jacinta Collins (ALP, VIC) Senator the Hon Joe Ludwig (ALP, QLD) Senator Linda Reynolds (LP, WA) until 12.10.2015 Senator Dean Smith (LP, WA) from 12.10.2015 Substituted Members Senator Lisa Singh (ALP, TAS) to replace Senator Jacinta Collins 5.8.2015 Senator Carol Brown (ALP, TAS) to replace Senator Jacinta Collins 3.9.2015 Senator Anne McEwen to replace Senator the Hon Joe Ludwig for 18.9.2015 Participating Members Senator Scott Ludlam (AG, WA) Senator Nick McKim (AG, TAS) Senator the Hon Jan McLucas (ALP, QLD) Senator Nova Peris (ALP, NT) Senator Larissa Waters (AG, QLD) Secretariat Ms Sophie Dunstone, Committee Secretary Ms Shennia Spillane, Principal Research Officer Ms Leah Ferris, Senior Research Officer Mr Hari Gupta, Senior Research Officer Mr Joshua Wrest, Research Officer Ms Jo-Anne Holmes, Administrative Officer Suite S1.61 Telephone: (02) 6277 3560 Parliament House Fax: (02) 6277 5794 CANBERRA ACT 2600 Email: [email protected] iii iv Table of contents Members of the committee ..............................................................................
    [Show full text]
  • ©Copyright 2008 Sunil Kumar Aggarwal
    ©Copyright 2008 Sunil Kumar Aggarwal The Medical Geography of Cannabinoid Botanicals in Washington State: Access, Delivery, and Distress Sunil Kumar Aggarwal A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2008 Program Authorized to Offer Degree: Geography University of Washington Graduate School This is to certify that I have examined this copy of a doctoral dissertation by Sunil Kumar Aggarwal and have found that it is complete and satisfactory in all respects, and that any and all revisions required by the final examining committee have been made. Chair of the Supervisory Committee: ___________________________________________________ Jonathan Mayer Reading Committee: __________________________________________________ Jonathan Mayer _________________________________________________ Richard Morrill ___________________________________________________ Craig ZumBrunnen ___________________________________________________ Gregory Carter ___________________________________________________ Ethan Russo Date:__________________________ In presenting this dissertation in partial fulfillment of the requirements for the doctoral degree at the University of Washington, I agree that the Library shall make its copies freely available for inspection. I further agree that extensive copying of the dissertation is allowable only for scholarly purposes, consistent with “fair use” as prescribed in the U.S. Copyright Law. Requests for copying or reproduction of this dissertation
    [Show full text]